Skip to main content
. 2015 Dec 8;7(3):3047–3058. doi: 10.18632/oncotarget.6504

Figure 6. miR-16 suppresses the PI3K/AKT and MAPK signaling pathways.

Figure 6

Western blotting was used to determine the expression levels of p-AKT, AKT, p-ERK, and ERK in CNE-1 and CNE-2 cells transfected with miR-16 mimics or inhibitor.